Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Boiron SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Boiron SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Botanix Pharmaceuticals Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Botanix Pharmaceuticals Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Boryung Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Boryung Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BPH Corporate Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BPH Corporate Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bradmer Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bradmer Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Brainstorm Cell Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Brainstorm Cell Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Brawn Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Brawn Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bristol-Myers Squibb Company Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bristol-Myers Squibb Company Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bruker Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bruker Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

BTG plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BTG plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bukwang pharm. co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bukwang pharm. co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Burcon Nutrascience Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Burcon Nutrascience Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

C & O Pharmaceutical Technology Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

C & O Pharmaceutical Technology Holdings Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cadence Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cadence Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cadila Healthcare Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cadila Healthcare Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cadus Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cadus Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cairo Pharmaceuticals & Chemical Industries Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cairo Pharmaceuticals & Chemical Industries Co. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Caleco Pharma Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Caleco Pharma Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Caliper Life Sciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Caliper Life Sciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Callisto Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Callisto Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Calypte Biomedical Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Calypte Biomedical Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Calyx Bio-Ventures Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Calyx Bio-Ventures Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Polynovo Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Polynovo Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cambrex Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cambrex Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Can-Fite BioPharma Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Can-Fite BioPharma Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

CanBas Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CanBas Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cangene Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cangene Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cannabis Science, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cannabis Science, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Canopus BioPharma Incorporated Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Canopus BioPharma Incorporated Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Caplin Point Laboratories Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Caplin Point Laboratories Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Caps Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Caps Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 34 pages

Capsalus Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Capsalus Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Capstone Therapeutics Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Capstone Therapeutics Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Caraco Pharmaceutical Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Caraco Pharmaceutical Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

CardioGenics Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CardioGenics Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cardiome Pharma Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cardiome Pharma Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

CardioVascular BioTherapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CardioVascular BioTherapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cardium Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cardium Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Carna Biosciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Carna Biosciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Catalyst Pharmaceutical Partners Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Catalyst Pharmaceutical Partners Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cavit Sciences Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cavit Sciences Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

CBio Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CBio Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

CCM Duopharma Biotech Berhad Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CCM Duopharma Biotech Berhad Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ceapro Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ceapro Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

CEL-SCI Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CEL-SCI Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Celera Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Celera Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Celestial Biolabs Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Celestial Biolabs Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Celgene Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Celgene Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cell Biotech Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cell Biotech Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cell Kinetics Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cell Kinetics Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1